Origene

OriGene is a well-established, revenue-generating provider of essential research reagents and custom services for the life sciences industry. With a broad portfolio centered on antibodies, cDNA clones, recombinant proteins, and viral vector solutions, it serves as a critical tools supplier for basic and translational research. The company leverages a strong technology platform in gene cloning, protein expression, and antibody validation to maintain its market position. Its business model is focused on catalog products and fee-for-service custom work, rather than internal therapeutic development.

Integrated platforms for gene cloning, recombinant protein expression, antibody development/validation (including UltraMAB specificity testing), and viral vector (Lenti/AAV) production. Also features transfection technologies (EZ-LNP™, ProteanFect™) for nucleic acid and protein delivery.

Operates in the highly competitive life science reagents market against giants like Thermo Fisher Scientific, Abcam, and Merck Millipore, as well as many niche players. Differentiation is achieved through a broad integrated product portfolio, emphasis on validation (e.g., UltraMAB), and specialized service offerings in cloning and viral vector production.